News, views and contacts from the global Pharmaceutical industry
 

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

May 2015

Top

India’s Strides to buy Aspen’s Australian generic pharmaceutical business
22 May 2015 India-based Strides Arcolab has signed an agreement with subsidiaries of South African drugmaker Aspen Pharmacare Holdings to acquire its generic pharmaceutical business in Australia and...

Aura Biosciences's AU-011 drug receives FDA orphan drug status for uveal melanoma
22 May 2015 Biotech firm Aura Biosciences has received orphan drug designation from the US Food and Drug Administration (FDA) for its drug, AU-011, to treat patients with uveal melanoma....

Eisai introduces anticancer agent Lenvima in Japan
21 May 2015 Eisai has introduced its in-house developed new anticancer agent Lenvima (lenvatinib mesylate) in Japan to treat patients with unresectable thyroid cancer....

Achillion and Janssen to develop hepatitis C virus assets
20 May 2015 Achillion Pharmaceuticals has signed a worldwide licence and collaboration agreement with Janssen Pharmaceuticals to develop and commercialise hepatitis C virus (HCV)...

Ireland’s Endo to acquire Par Pharmaceutical for $8bn
20 May 2015 Ireland-based Endo International has signed an agreement to acquire Par Pharmaceutical Holdings from TPG for $8.05bn....

AstraZeneca to develop new $285m biologics manufacturing facility in Sweden
19 May 2015 AstraZeneca has unveiled plans to invest around $285m to develop a new advanced facility to manufacture biological medicines in Södertälje, Sweden....

Ablynx and Genzyme partner for multiple sclerosis research project
19 May 2015 Belgian-based Ablynx has signed an exclusive collaboration agreement with Sanofi subsidiary Genzyme for a research project on multiple sclerosis (MS)....

NantPharma to buy Sorrento’s Igdrasol
18 May 2015 NantWorks ecosystem of companies member NantPharma has agreed to acquire a wholly owned subsidiary of Sorrento, Igdrasol, in a deal worth $1.3bn....

Pernix’s migraine drug Treximet gets FDA approval to treat paediatric patients
18 May 2015 Pernix Therapeutics Holdings has obtained approval from the US Food and Drug Administration (FDA) for its Treximet (sumatriptan and naproxen sodium) for use in paediatric patients aged 12 years...

Lupin buys Brazilian pharmaceutical firm Medquímica
15 May 2015 India-based drugmaker Lupin has acquired 100% equity interest in Brazilian pharmaceutical firm Medquímica Indústria Farmacêutica....

Cortendo and Antisense to develop ATL1103 for endocrinology applications
15 May 2015 US firm Cortendo has signed an exclusive licence agreement with Australia-based Antisense Therapeutics to develop and commercialise ATL1103 for endocrinology applications....

Alnylam’s revusiran gets FDA orphan drug designation for ATTR Amyloidosis
14 May 2015 Alnylam Pharmaceuticals has received orphan drug designation from the US Food and Drug Administration (FDA) for its revusiran to treat transthyretin (TTR) mediated amyloidosis (ATTR amyloidosis). ...

Sanofi and Selecta partner to develop new immunotherapy for celiac disease
14 May 2015 French drugmaker Sanofi has exercised its option with Selecta Biosciences for second exclusive licence to develop an immunotherapy to treat celiac disease....

Baxter acquires Sigma-Tau’s Oncaspar product portfolio for $900m
14 May 2015 Baxter International has entered an agreement with Sigma-Tau Finanziaria to acquire its Oncaspar (pegaspargase) product portfolio for around $900m....

Merck’s evofosfamide obtains FDA fast-track designation for pancreatic cancer
13 May 2015 Merck has received fast-track designation from the US Food and Drug Administration (FDA) for its evofosfamide (previously known as TH-302) to treat patients with advanced pancreatic cancer....

Endo acquires Aspen subsidiary’s portfolio of branded and generic products
13 May 2015 Endo International has acquired a broad portfolio of branded and generic injectable products from a subsidiary of publicly-traded South African company Aspen Holdings....

Eli Lilly and BioNTech to develop new cancer immunotherapies
12 May 2015 US-based Eli Lilly and Company has signed a research collaboration agreement with German firm BioNTech to discover new cancer immunotherapies....

Pfizer purchases minority interest in Dutch firm AM-Pharma
12 May 2015 US-based drugmaker Pfizer has purchased a minority equity interest and received an exclusive option to acquire the remaining equity in a Dutch biopharmaceutical firm, AM-Pharma....

April’s top stories: Teva’s offer to Mylan, Takeda settles with US
11 May 2015 Mylan buys Perrigo and Teva made bid to acquire Mylan, Takeda to pay $2.4bn to settle Actos drug claims in US, and researchers developed a new biochip to enhance drug...

Novartis receives EU approval for Zykadia to treat ALK+ NSCLC
11 May 2015 Novartis has received approval from the European Commission for its Zykadia (ceritinib) to treat adult patients with anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung...

GSK and UNC-Chapel Hill to create HIV Cure Centre and new company
11 May 2015 GlaxoSmithKline (GSK) has entered a public-private partnership with the University of North Carolina at Chapel Hill (UNC-Chapel Hill) to create a HIV Cure Centre and a new company, Qura...


cachename:Newscachekey:rd-1665407042_1857678299_rd-488908060_1243308781_ap1243308781_1857678299_874850511